CIRM Funded Clinical Trials
Phase I Trial of Locoregionally Delivered Autologous B7-H3 CAR T Cells (B7-H3CART) in Adults with Recurrent Glioblastoma Multiforme
Disease Area:
Brain Cancer
Trial Sponsor:
Stanford University
Trial Stage:
Phase 1
Trial Status:
Launching
Targeted Enrollment:
N/A
